On Tuesday, Gossamer Bio Inc (NASDAQ: GOSS) opened higher 5.34% from the last session, before settling in for the closing price of $1.31. Price fluctuations for GOSS have ranged from $0.50 to $1.60 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 76.06% at the time writing. With a float of $182.04 million, this company’s outstanding shares have now reached $226.60 million.
The firm has a total of 135 workers. Let’s measure their productivity. In terms of profitability, gross margin is 97.34%, operating margin of -56.03%, and the pretax margin is -60.96%.
Gossamer Bio Inc (GOSS) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Gossamer Bio Inc is 19.67%, while institutional ownership is 59.06%. The most recent insider transaction that took place on Jun 24 ’24, was worth 1,260. In this transaction Chief Medical Officer of this company sold 1,908 shares at a rate of $0.66, taking the stock ownership to the 196,891 shares. Before that another transaction happened on Jun 21 ’24, when Company’s President & CEO bought 372,000 for $0.67, making the entire transaction worth $250,282. This insider now owns 5,408,073 shares in total.
Gossamer Bio Inc (GOSS) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 76.06% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 26.42% during the next five years compared to 11.99% growth over the previous five years of trading.
Gossamer Bio Inc (NASDAQ: GOSS) Trading Performance Indicators
Check out the current performance indicators for Gossamer Bio Inc (GOSS). In the past quarter, the stock posted a quick ratio of 6.74. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.33, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Gossamer Bio Inc (GOSS)
Analysing the last 5-days average volume posted by the [Gossamer Bio Inc, GOSS], we can find that recorded value of 2.46 million was better than the volume posted last year of 1.33 million. As of the previous 9 days, the stock’s Stochastic %D was 83.12%. Additionally, its Average True Range was 0.11.
During the past 100 days, Gossamer Bio Inc’s (GOSS) raw stochastic average was set at 93.49%, which indicates a significant increase from 90.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 68.68% in the past 14 days, which was lower than the 73.45% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9580, while its 200-day Moving Average is $0.8810. Now, the first resistance to watch is $1.4400. This is followed by the second major resistance level at $1.5000. The third major resistance level sits at $1.5700. If the price goes on to break the first support level at $1.3100, it is likely to go to the next support level at $1.2400. Should the price break the second support level, the third support level stands at $1.1800.
Gossamer Bio Inc (NASDAQ: GOSS) Key Stats
There are currently 226,604K shares outstanding in the company with a market cap of 312.71 million. Presently, the company’s annual sales total 0 K according to its annual income of -179,820 K. Last quarter, the company’s sales amounted to 9,480 K and its income totaled -30,800 K.
